Grimes & Company’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,609
| Closed | -$59.2K | – | 402 |
|
|
2024
Q3 | $59.2K | Hold |
33,609
| – | – | ﹤0.01% | 357 |
|
|
2024
Q2 | $39.3K | Buy |
33,609
+60
| +0.2% | +$70 | ﹤0.01% | 342 |
|
|
2024
Q1 | $303K | Sell |
33,549
-751
| -2% | -$6.79K | 0.01% | 269 |
|
|
2023
Q4 | $373K | Sell |
34,300
-561
| -2% | -$6.1K | 0.01% | 245 |
|
|
2023
Q3 | $281K | Buy |
34,861
+110
| +0.3% | +$885 | 0.01% | 248 |
|
|
2023
Q2 | $377K | Hold |
34,751
| – | – | 0.01% | 225 |
|
|
2023
Q1 | $240K | Buy |
34,751
+122
| +0.4% | +$842 | 0.01% | 257 |
|
|
2022
Q4 | $138K | Hold |
34,629
| – | – | 0.01% | 275 |
|
|
2022
Q3 | $230K | Buy |
34,629
+750
| +2% | +$4.98K | 0.01% | 245 |
|
|
2022
Q2 | $164K | Buy |
33,879
+1,114
| +3% | +$5.39K | 0.01% | 260 |
|
|
2022
Q1 | $306K | Buy |
32,765
+7,085
| +28% | +$66.2K | 0.02% | 238 |
|
|
2021
Q4 | $305K | Sell |
25,680
-3,448
| -12% | -$41K | 0.01% | 239 |
|
|
2021
Q3 | $331K | Buy |
29,128
+2,697
| +10% | +$30.6K | 0.01% | 229 |
|
|
2021
Q2 | $474K | Buy |
26,431
+2,606
| +11% | +$46.7K | 0.02% | 203 |
|
|
2021
Q1 | $369K | Buy |
23,825
+11,575
| +94% | +$179K | 0.02% | 214 |
|
|
2020
Q4 | $149K | Buy |
12,250
+1,000
| +9% | +$12.2K | 0.01% | 258 |
|
|
2020
Q3 | $145K | Buy |
11,250
+7,125
| +173% | +$91.8K | 0.01% | 237 |
|
|
2020
Q2 | $42K | Buy |
+4,125
| New | +$42K | ﹤0.01% | 244 |
|